documents: FDA-2023-N-2177-0019

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2023-N-2177-0019 FDA FDA-2023-N-2177 PRIA Reference 35 - HHS - Valuing COVID-19 Mortality and Morbidity Risk Reductions in U.S. Department of Health and Human Services Regulatory Impact Analyses RE: Medical Devices; Laboratory Developed Tests Supporting & Related Material Background Material 2023-10-04T04:00:00Z 2023 10     2023-10-05T14:34:23Z   0 0 090000648601d2a8

Links from other tables